Contact Kinex Pharmaceuticals

About Us Team Pipeline News Contact Us Careers Home
Kinex Named to Science Coalition List

Kinex to Present at the 101st Annual AACR Meeting

Kinex Technology Highlighted at American Chemical Society Symposium

Charles E. Lannon Appointed as Vice-Chairman of the Board at Kinex Pharmaceuticals

Kinex Pharmaceuticals Initiates a Phase 2 Clinical Trial of KX2-391 in Patients with Prostate Cancer

More headlines ...

Kinex News


Back to headlines

June 15, 2007
Insyte Consulting Honors Kinex Pharmaceuticals

Kinex Pharmaceuticals was honored by Insyte Consulting at a reception held at the Albright Knox Art Gallery on June 13, 2007. Insyte Consulting assists Western New York manufacturing and technology companies to overcome their strategic and tactical business challenges. Through the Business Development Fund (BDF), which is managed by Insyte, they make strategic investments in companies that have the potential to impact the local economy. Kinex received a $200,000 investment from the BDF in its seed round of financing in 2005.

“Kinex Pharmaceuticals is the model for the transformation of the Western New York economy” said Jack McGowan of Insyte during the award presentation. Co-Founders Lyn Dyster and David Hangauer accepted the award on behalf of the Company. The event was attended by prominent business and civic leaders from the Buffalo, New York area.